| |||||||
Former Names C57BL/6-Tg(ACTB-OVA)916Jen/J (Changed: 08-MAY-08 ) C57BL/6-Tg(Actb-OVA)916Jen/J (Changed: 29-MAR-05 ) Type Mutant Strain; Transgenic; Additional information on Genetically Engineered Mutant Mice. Mating System Hemizygote x +/+ sibling (Female x Male) Species laboratory mouse Generation N?+3 (05-DEC-07) Donating Investigator Marc Jenkins, University of Minnesota Description
Mice that are hemizygous for the transgene are viable, normal in size and do not display any gross physical or behavioral abnormalities. These transgenic mice express the membrane bound chicken ovalbumin OVA gene under the direction of the chicken beta actin promoter coupled with the cytomegalovirus (CMV) immediate-early enhancer. Chicken ovalbumin expression is detected by immunohistochemical analysis of all tissues. Splenocytes from transgenic mice display the 254-267-Kb complex, which is recognized by T-cells from the transgenic strain C57BL/6-Tg(TcraTcrb)1100Mjb/J (Stock No. 3831) and the 323-339-I-Ab complex, which is recognized by T-cells from the transgenic C57BL/6-Tg(TcraTcrb)425Cbn/J (Stock No. 4194). Skin grafts from transgenic mice are rejected by C57BL/6 recipients. Ovalbumin antigen specific T cells can be tracked in vivo. This mutant mouse strain represents a model that may be useful in studies of adoptive transfer and graft rejection as source for tissue and cells expressing a defined minor histocompatibility antigen.Development
A transgenic construct containing sequence encoding chicken ovalbumin, the leader of the H-2Kb and the transmembrane region of the H-2Db gene under the control of a chicken beta actin promoter coupled with the cytomegalovirus (CMV) immediate-early enhancer, and a rabbit beta-globin poly(A) signal, was introduced into C57BL/6 donor eggs. The resulting male transgenic mouse (916, also referred to as Act-mOVA-II) was crossed to C57BL/6 female mice.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of ACTB
005703 B6.Cg-Tg(ACTFLPe)9205Dym/J 006055 B6.Cg-Tg(CAG-Bgeo,-DsRed*MST)1Nagy/J 003800 B6;SJL-Tg(ACTFLPe)9205Dym/J 005863 C57BL/6J-Tg(ACTB-DDAH1)1Jpck/J 002981 DBA/2-Tg(xstpx-lacZ)36And/J 003376 FVB/N-Tg(ACTB-cre)2Mrt/J 008200 FVB/N-Tg(CAG-EGFP,-ALPP)2.6Ggc/J 005438 STOCK Tg(CAG-Bgeo,-DsRed*MST)1Nagy/J View Strains carrying other alleles of ACTB (8 strains)
Strains carrying other alleles of OVA
005432 C57BL/6-Tg(Ins2-OVA)307Wehi/WehiJ 005433 C57BL/6-Tg(Ins2-OVA)59Wehi/WehiJ 005431 C57BL/6-Tg(Ins2-TFRC/OVA)296Wehi/WehiJ View Strains carrying other alleles of OVA (3 strains)
Genetic Quality Control Annual Report
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Tg(CAG-OVA)916Jen/?
C57BL/6-Tg(CAG-OVA)916Jen
- cellular phenotype
- abnormal cell content/ morphology (MGI Ref ID J:91742)
- most cells of the body express a membrane bound form of chicken ovalbumin on their cell surface
- immune system phenotype
- abnormal dendritic cell antigen presentation (MGI Ref ID J:91742)
- dendritic cells in the skin present an epitope of chicken ovalbumin in complex with the MHC allele Kb
- splenocytes are able to activate OT-I and OT-II transgenic T cells when cultured in vitro
- decreased length of allograft survival (MGI Ref ID J:91742)
- full thickness tail skin grafted from transgenic mice to C57BL/6 mice have a mean survival time of 33.9 days compared a mean survival time of over 200 days for non-transgenic donors
- recipient mice show accelerated rejection (18 days) when grafted with transgenic tail skin a second time
- recipient mice also show accelerated rejection when adoptively transferred with OT-I or OT-II T cells (OT-I = Tg(TcraTcrb)1100Mjb, OT-II = Tg(TcraTcrb)425Cbn)
- when recipient mice lack T cells (Tcratm1Mom homozygotes), rejection of the transgenic skin grafts fail to occur
- when recipient mice lack CD8 T cells (Cd8atm1Mak homozygotes), transgenic skin grafts shrink rapidly to 10-30% of their original size but then survive indefinitely
- when recipient mice lack CD4 T cells (H2-Ab1tm1Gru homozygotes), transgenic skin grafts remain healthy for the first 40 days after which they start progressively contracting with 25% of the grafts being lost by 115 days
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Research Tools
Genetics Research (Tissue/Cell Markers: multiple)
Immunology and Inflammation Research (T Cell Receptor Transgenics)
| Allele Symbol | Tg(CAG-OVA)916Jen | ||
|---|---|---|---|
| Allele Name | transgene insertion 916, Marc K Jenkins | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | Act-mOVA; Tg(ACTB-OVA)916Jen; Tg(CAG-OVA)916Jen; | ||
| Mutation Made By | Ben Ehst, University of Minnesota | ||
| Strain of Origin | C57BL/6 | ||
| Expressed Gene | OVA, ovalbumin, chicken | ||
| Promoter | ACTB, actin, beta, human | ||
| Molecular Note | The transgene consists of a full-length chicken ovalbumin cDNA preceded by the 5' leader sequence of the mouse H2-Kb gene and followed by the DNA sequence encoding the short extracellular spacer and transmembrane domain of the mouse H2-Db gene joined to the rabbit beta-globin polyadenylation signal; its expression is driven by the chicken beta-actin promoter under control of the CMV immediate early enhancer. Ovalbumin expression was detected immunohistochemically on the surfaces of cells of all organs and shown to function in skin-graft experiments as a minor histocompatibility antigen that triggered graft rejection by a mechanism involving both CD4 and CD8 T lymphocytes. [MGI Ref ID J:91742] | ||
Genotyping Protocols
Tg(CAG-OVA)916Jen, SEP PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Ehst BD; Ingulli E; Jenkins MK. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant 3(11):1355-62. [PubMed: 14525595] [MGI Ref ID J:91742]
Tg(CAG-OVA)916Jen relatedJanssen EM; Droin NM; Lemmens EE; Pinkoski MJ; Bensinger SJ; Ehst BD; Griffith TS; Green DR; Schoenberger SP. 2005. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434(7029):88-93. [PubMed: 15744305] [MGI Ref ID J:96586]
Kang J; Huddleston SJ; Fraser JM; Khoruts A. 2008. De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J Leukoc Biol 83(5):1230-9. [PubMed: 18270248] [MGI Ref ID J:134458]
Mayerova D; Parke EA; Bursch LS; Odumade OA; Hogquist KA. 2004. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21(3):391-400. [PubMed: 15357950] [MGI Ref ID J:93786]
Animal Health Reports
Room Number AX12
Colony Maintenance
Breeding & Husbandry As preliminary attempts to make a homozygous colony at The Jackson Laboratory yielded smaller than normal homozygous males (September 2006), this strain is maintained by breeding hemizygotes to wildtype siblings or C57BL/6J mice. Mating System Hemizygote x +/+ sibling (Female x Male) Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $122.80 Female or Male Hemizygous for Tg(CAG-OVA)916Jen *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $175.05 Hemizygous for Tg(CAG-OVA)916Jen x Noncarrier $175.05 Noncarrier x Hemizygous for Tg(CAG-OVA)916Jen
| Supply Notes |
|
|---|
| Pricing for International shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $159.70 Female or Male Hemizygous for Tg(CAG-OVA)916Jen *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $227.60 Hemizygous for Tg(CAG-OVA)916Jen x Noncarrier $227.60 Noncarrier x Hemizygous for Tg(CAG-OVA)916Jen
| Supply Notes |
|
|---|
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.